News Prime minister accused of being "in denial" about NHS crisis PM under fire over A&E waiting times.
News Government in denial over NHS funding, say MPs No 10 under fire over health funding from Public Accounts Committee.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
